Thomas Look

5.4k total citations · 1 hit paper
36 papers, 3.1k citations indexed

About

Thomas Look is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Thomas Look has authored 36 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Immunology. Recurrent topics in Thomas Look's work include CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Thomas Look is often cited by papers focused on CAR-T cell therapy research (5 papers), Immune Cell Function and Interaction (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). Thomas Look collaborates with scholars based in United States, Switzerland and Germany. Thomas Look's co-authors include Harry A. Drabkin, Robert S. Lasher, J Gao, KS Chang, Janet D. Rowley, Emily Whisenant, Joshua T. Trujillo, Paul A. Erickson, Kristian Helin and Marc Vidal and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Blood.

In The Last Decade

Thomas Look

36 papers receiving 3.1k citations

Hit Papers

SCFFBW7 regulates cellular apoptosis by targeting MCL1 fo... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Look United States 19 2.1k 1.0k 882 388 332 36 3.1k
Marc R. Mansour United Kingdom 26 1.9k 0.9× 651 0.6× 557 0.6× 633 1.6× 316 1.0× 59 2.9k
V.V.V.S. Murty United States 26 2.5k 1.2× 801 0.8× 606 0.7× 180 0.5× 352 1.1× 42 3.8k
Blanca Scheijen Netherlands 24 1.5k 0.7× 566 0.6× 615 0.7× 460 1.2× 311 0.9× 53 2.6k
Norihiko Kawamata Japan 38 2.2k 1.1× 745 0.7× 1.4k 1.5× 381 1.0× 467 1.4× 96 4.0k
Maria Luisa Sulis United States 19 2.2k 1.0× 764 0.8× 638 0.7× 876 2.3× 399 1.2× 52 3.2k
Shinobu Tsuzuki Japan 28 1.7k 0.8× 688 0.7× 656 0.7× 364 0.9× 560 1.7× 86 3.1k
Eric H. Westin United States 28 2.2k 1.0× 462 0.5× 819 0.9× 205 0.5× 759 2.3× 66 3.6k
Tomohiko Taki Japan 36 2.4k 1.1× 1.8k 1.8× 402 0.5× 715 1.8× 328 1.0× 127 3.7k
Josée Hébert Canada 33 2.2k 1.0× 947 0.9× 550 0.6× 251 0.6× 443 1.3× 93 3.1k
Catherine Lavau United States 25 3.3k 1.6× 2.0k 1.9× 377 0.4× 308 0.8× 546 1.6× 41 4.0k

Countries citing papers authored by Thomas Look

Since Specialization
Citations

This map shows the geographic impact of Thomas Look's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Look with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Look more than expected).

Fields of papers citing papers by Thomas Look

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Look. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Look. The network helps show where Thomas Look may publish in the future.

Co-authorship network of co-authors of Thomas Look

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Look. A scholar is included among the top collaborators of Thomas Look based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Look. Thomas Look is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Look, Thomas, Roman Sankowski, Serena Fazio, et al.. (2025). CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines. Cell Reports Medicine. 6(2). 101931–101931. 8 indexed citations
2.
Gilardoni, Ettore, Jacqueline Mock, Frauke Seehusen, et al.. (2024). A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors. EMBO Molecular Medicine. 16(4). 904–926. 4 indexed citations
3.
Mellett, Mark, Thomas Look, Tobias Weiß, et al.. (2024). Synthetic mRNAs Containing Minimalistic Untranslated Regions Are Highly Functional In Vitro and In Vivo. Cells. 13(15). 1242–1242. 6 indexed citations
4.
Gilardoni, Ettore, Thomas Look, Miaomiao Sun, et al.. (2024). An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade. Journal for ImmunoTherapy of Cancer. 12(8). e008504–e008504. 1 indexed citations
5.
Look, Thomas, Emanuele Puca, Daniel S. Kirschenbaum, et al.. (2023). Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell–dependent regression of glioblastoma. Science Translational Medicine. 15(697). eadf2281–eadf2281. 24 indexed citations
6.
Xu, Huaming, Zhijian Li, Chao‐Chung Kuo, et al.. (2023). A lncRNA identifies Irf8 enhancer element in negative feedback control of dendritic cell differentiation. eLife. 12. 9 indexed citations
7.
Look, Thomas, et al.. (2023). Protocol for the expansion of mouse immune effector cells for in vitro and in vivo studies. STAR Protocols. 4(4). 102700–102700. 3 indexed citations
8.
Look, Thomas, Patrick Roth, Steve Pascolo, et al.. (2022). Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma. Clinical Cancer Research. 28(21). 4747–4756. 55 indexed citations
9.
Sontag, Stephanie, Thomas Look, Birgit Plümäkers, et al.. (2022). Toward Clinical Application of Leukocyte Counts Based on Targeted DNA Methylation Analysis. Clinical Chemistry. 68(5). 646–656. 12 indexed citations
10.
Herrmann, Andreas, Christoph Lahtz, Toshikage Nagao, et al.. (2017). CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity. Cancer Research. 77(18). 5118–5128. 38 indexed citations
11.
Inuzuka, Hiroyuki, Shavali Shaik, Ichiro Onoyama, et al.. (2011). SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature. 471(7336). 104–109. 537 indexed citations breakdown →
12.
Kuchenbauer, Florian, Susanne Schnittger, Thomas Look, et al.. (2006). Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1‐ETO. British Journal of Haematology. 134(6). 616–619. 47 indexed citations
13.
Rubnitz, Jeffrey E. & Thomas Look. (1998). Molecular basis of leukemogenesis. Current Opinion in Hematology. 5(4). 264–270. 22 indexed citations
14.
Crist, W M, J J Shuster, Thomas Look, et al.. (1992). Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia. 6. 162–165. 28 indexed citations
15.
Woods, William G., Mendel Tuchman, Mark L. Bernstein, et al.. (1992). Screening for Neuroblastoma in North America. The Pediatric Infectious Disease Journal. 14(4). 312–319. 4 indexed citations
16.
Koch, Alisa E., James C. Burrows, Peter H. Domer, et al.. (1992). Monoclonal Antibodies Defining Shared Human Macrophage-Endothelial Antigens. Pathobiology. 60(2). 59–67. 7 indexed citations
17.
Trueworthy, Robert C., Jonathan J. Shuster, Thomas Look, et al.. (1992). Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.. Journal of Clinical Oncology. 10(4). 606–613. 168 indexed citations
18.
Woods, William G., Mendel Tuchman, Mark L. Bernstein, et al.. (1992). Screening for Neuroblastoma in North America 2-Year Results from the Quebec Project. Journal of Pediatric Hematology/Oncology. 14(4). 312–319. 32 indexed citations
19.
Brodeur, Garrett M., C G Azar, Bruce A. Kaufman, et al.. (1992). Neuroblastoma: Effect of genetic factors on prognosis and treatment. Cancer. 70(S4). 1685–1694. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026